Related Experiment Videos
Treatment of bronchial obstruction in asthmatic children
Insights
Clenbuterol offers 12-hour bronchodilation in children with asthma. Other medications like ipratropium bromide, fenoterol, theophylline, and ambroxol hydrochloride also effectively manage asthma symptoms, including cough and sputum.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
Background:
- Asthma in children presents challenges in managing bronchoconstriction and associated symptoms like cough and sputum.
- Effective bronchodilators and anti-inflammatory agents are crucial for controlling pediatric asthma exacerbations and long-term management.
Purpose of the Study:
- To review the efficacy of various pharmacological agents in managing asthma symptoms in children.
- To highlight the duration of action and specific benefits of different asthma medications.
Main Methods:
- Literature review of studies evaluating bronchodilators and anti-asthmatic medications in pediatric populations.
- Analysis of reported efficacy, duration of action, and symptom relief provided by individual drugs and combinations.
Main Results:
- Clenbuterol demonstrates 12-hour bronchodilation in asthmatic children.
- Ipratropium bromide and fenoterol combination effectively reduces cough linked to bronchial obstruction.
- Sustained-release theophylline maintains therapeutic levels for 16 hours.
- Ambroxol hydrochloride aids in reducing cough and sputum.
- Cromoglycate and ketotifen are suitable for long-term asthma control.
- Combination bronchodilators may improve nocturnal asthma management.
Conclusions:
- A range of pharmacological options exist for pediatric asthma, each with specific benefits.
- Medication choice should consider symptom profile, duration of action, and long-term control needs.
- Combination therapy can enhance asthma control, particularly for nocturnal symptoms.
Abstract:
In asthmatic children, clenbuterol causes bronchodilatation for 12h. Ipratropium bromide plus fenoterol is effective in stopping dry irritable cough related to bronchial obstruction. Sustained-release theophylline is effective with therapeutic serum and saliva concentrations for 16h. Ambroxol hydrochloride provides an additional therapy for bronchial obstructure since it reduces cough and sputum output. Cromoglycate and ketotifen are appropriate for long term treatment, and a combination of bronchodilators may offer better control of nocturnal asthma.